Clinical Edge

Summaries of Must-Read Clinical Literature, Guidelines, and FDA Actions

Occult Gynecologic Cancer in Hysterectomy or Myomectomy

Obstet Gynecol; ePub 2018 Mar 8; Desai, et al

Among women undergoing hysterectomies and varied by age and surgical route, prevalence of occult corpus uteri, cervical, and ovarian malignancy was 1.44%, 0.60%, and 0.19%. The secondary analysis of data from the 2014-2015 American College of Surgeons National Surgical Quality Improvement Program included 24,076 women undergoing hysterectomy and 2,368 women undergoing myomectomy. The primary outcome measure was pathology-confirmed malignancy in the corpus uteri, cervix uteri, and ovary. Researchers found:

  • Malignancy of the corpus uteri was found in 1.44% of the women undergoing hysterectomy.
  • The prevalence varied considerably across surgical routes with the rate being 0.23% in laparoscopic supracervical hysterectomy and 1.89% in total laparoscopic or laparoscopic-assisted vaginal hysterectomy.
  • Older women were significantly more like to have preoperatively undetected malignancy of the corpus uteri.

Citation:

Desai VB, Wright JD, Schwartz PE, et al. Occult gynecologic cancer in women undergoing hysterectomy or myomectomy for benign indications. [Published online ahead of print March 8, 2018]. Obstet Gynecol. doi:10.1097/AOG.0000000000002521.

This Week's Must Reads

VTE risk for continuous cycle oral contraceptives, Li J et al. JAMA Intern Med. 2018 Oct 1. doi:10.1001/jamainternmed.2018.4251

Long-Acting Opioid Use During Delivery Hospitalizations, Obstet Gynecol; ePub 2018 Sep 7; Duffy, et al

Provider Counseling in Hormonal Contraception, Contraception; ePub 2018 Sep 15; Craig, et al

Weight Gain & Hypertensive Disorders in Pregnancy, Obstet Gynecol; ePub 2018 Sep 7; Dude, et al

Vitamin D Levels and Ovarian Reserve, Fertil Steril; 2018 Sep; Shapiro, Darmon, et al

Must Reads in Gynecologic Cancer

USPSTF on Screening for Cervical Cancer, JAMA; 2018 Aug 21; US Preventive Services Task Force

Gynecologic Issues in Adolescents with Cancer, Obstet Gynecol; ePub 2018 Aug; ACOG, et al

Morcellation of incidental uterine sarcomas doubled 10-year mortality risk in Norwegian study, Bretthauer M et al. European Journal of Cancer; 2018, 62-68 https://doi.org/10.1016/j.ejca.2018.06.007

Place of Death in Patients with Gynecologic Cancer, Obstet Gynecol; ePub 2018 May 7; Hicks-Courant, et al

Recent IUD Use and Risk of Cervical Cancer, Contraception; ePub 2018 Apr 16; Averbach, et al